Cardiovascular Research - Immunity and Atherosclerosis
431 – 440 of 550
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
(
- Contribution to journal › Article
-
Mark
Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
(
- Contribution to journal › Article
-
Mark
Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide
(
- Contribution to journal › Article
- 2008
-
Mark
Evaluation of the T cell response to apolipoprotein B100 (ApoB100): A new opportunity for immunotherapy against atherosclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men
(
- Contribution to journal › Article
-
Mark
Interleukin-1 beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells
(
- Contribution to journal › Article
-
Mark
Athero-protective effects of a human apoB-100 related peptide vaccine in apoE-/- mice are modulated by peptide dose and time of initiation of high fat diet
2008) American College of Cardiology 57th Annual Scientific Session In Journal of the American College of Cardiology 51(10, Suppl. 1). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
A compare between myocardial topical negative pressure levels of-25 mmHg and-50 mmHg in a porcine model
(
- Contribution to journal › Article